Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma

27 Sept 2024

Abstract excerpt

Background: Investigating oncogenes and the mechanisms driving oncogenic processes in human tumors is imperative for the development of efficient therapies. Peroxidasin (PXDN) has been reported to play a critical role in tissue development and homeostasis. However, the role of PXDN in the occurrence and development of Nasopharyngeal Carcinoma (NPC) remains unknown. Methods: experiments were conducted to explore...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Redox biology and oxidative stress

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39399179
DOI: 10.3389/fonc.2024.1463011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinomaPMID 39399179Read ↗

The oncogenic role and prognostic value of PXDN in human stomach adenocarcinomaSemantic proximity Read ↗

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read ↗

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatmentSemantic proximity Read ↗

Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma.Semantic proximity Read ↗

Focusing on the Abnormal Events of NPC1, NPC2, and NPC1L1 in Pan-Cancer and Further Constructing LUAD and KICH Prediction Models.Semantic proximity Read ↗

Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Semantic proximity Read ↗

Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challengesSemantic proximity Read ↗

Prognostic and immune infiltrative biomarkers of CENPO in pan- cancer and its relationship with lung adenocarcinoma cell proliferation and metastasisSemantic proximity Read ↗

Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.Semantic proximity Read ↗

Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation.Semantic proximity Read ↗

PLCXD2 expression relates to the immune microenvironment and prognosis of head and neck squamous cell carcinomaSemantic proximity Read ↗

Pan-cancer analysis of GINS1 identifies its prognostic and immunotherapy predictive value with in vitro experimental validation in nasopharyngeal carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.